| A Phase 1 Study of Tegoprazan on Healthy Male Volunteers (NCT03530228) | HK inno.N Corporation | 2018-05-01 |
| Healthy Summer Learners (NCT03321071) | University of South Carolina | 2018-05-01 |
| Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) (NCT03493945) | National Cancer Institute (NCI) | 2018-05-01 |
| Mood Effects of Serotonin Agonists (NCT03790358) | University of Chicago | 2018-05-01 |
| A Study of PTS for Patients With Solid Tumors (NCT03448211) | PTS International Inc. | 2018-05-01 |
| Study of Palliative Radiation Therapy vs. no Palliative Radiation Therapy for Patients With High Risk Bone Metastases That Are Not Causing Significant Pain (NCT03523351) | Memorial Sloan Kettering Cancer Center | 2018-05-01 |
| Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers (NCT03564158) | Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.) | 2018-05-01 |
| Bcl-XL_42-CAF09b Vaccination for Patients With Prostate Cancer With Lymph Node Metastases (NCT03412786) | Herlev Hospital | 2018-05-01 |
| Gemcitabine & Nab-Paclitaxel in Pancreatic Adenocarcinoma With Positive Peritoneal Cytology (NCT03703089) | Benaroya Research Institute | 2018-05-01 |
| MANP in African Americans With Hypertension (NCT04542681) | Mayo Clinic | 2018-05-01 |
| Evaluation of Abuse Liability of Very Low Nicotine (VLN) Mentholated Cigarettes (NCT03559725) | 22nd Century Group, Inc. | 2018-05-01 |
| The Use of AVL-3288 to Potentiate the Attention-Enhancing Effects of Low-Dose Nicotine (NCT03281694) | University of Maryland, Baltimore | 2018-05-01 |
| GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors (NCT03576131) | Genmab | 2018-04-30 |
| Radiation Therapy and M7824 in Treating Patients With Metastatic Hormone Receptor Positive, HER2 Negative Breast Cancer (NCT03524170) | M.D. Anderson Cancer Center | 2018-04-30 |
| Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients (NCT03458728) | Bayer | 2018-04-30 |
| Bioavailability Pilot Study of Versus W0035 Versus Stromectol (NCT03717558) | Pierre Fabre Dermatology | 2018-04-30 |
| Evaluate Safety and Pharmacokinetic To Assess Bronchopulmonary Disposition of Intravenous Delafloxacin in Healthy Adults (NCT03534622) | Melinta Therapeutics, Inc. | 2018-04-30 |
| Testing Lenvatinib and Cetuximab in Patients With Advanced Head and Neck Squamous Cell Carcinoma and Cutaneous Squamous Cell Carcinoma (NCT03524326) | Memorial Sloan Kettering Cancer Center | 2018-04-30 |
| Localization of Peripheral Pulmonary Lesions: A Pilot Study (NCT03536026) | Washington University School of Medicine | 2018-04-30 |
| A Single Dose Crossover Study In Healthy Subjects To Evaluate Different Formulations Of PF-06882961 (NCT03492697) | Pfizer | 2018-04-30 |
| A Study to Evaluate the Mass Balance, Pharmacokinetics (PK), Metabolism and Excretion of TAK-954 Containing Microtracer ([14C]-TAK-954) in Healthy Male Participants (NCT03500224) | Millennium Pharmaceuticals, Inc. | 2018-04-30 |
| Differences by Sex and Genotype in the Effects of Stress on Executive Functions (NCT04273880) | University of British Columbia | 2018-04-28 |
| Study of Chiauranib in Patients With Advanced Hepatocellular Carcinoma (NCT03245190) | Chipscreen Biosciences, Ltd. | 2018-04-28 |
| Cladribine Dose Escalation in Conditioning Regimen Prior to Allo-HSCT for Refractory Acute Leukemia and Myelodysplastic Syndromes (NCT03235973) | Institut Paoli-Calmettes | 2018-04-28 |
| A Study in Healthy Smokers to Investigate the Effect of Food on the Bioavailability of Cytisine in a New Formulation (NCT03509948) | Achieve Life Sciences | 2018-04-27 |
| Pevonedistat and Ibrutinib in Treating Participants With Relapsed or Refractory CLL or Non-Hodgkin Lymphoma (NCT03479268) | City of Hope Medical Center | 2018-04-27 |
| Body Compartment Pharmacokinetics of Anti- Retroviral Agents That May be Used for Future HIV Post- Exposure Prophylaxis. (NCT03472963) | Emory University | 2018-04-27 |
| Safety and Efficacy of Efavaleukin Alfa in Subjects With Steroid Refractory Chronic Graft Versus Host Disease (NCT03422627) | Amgen | 2018-04-27 |
| Copanlisib Chinese PK Study (NCT03498430) | Bayer | 2018-04-27 |
| This Study in Healthy Men and Women Tests How the Body Takes up BI 409306 (NCT03505151) | Boehringer Ingelheim | 2018-04-27 |
| Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient (NCT03576014) | SL VAXiGEN | 2018-04-27 |
| Study of ISU104, Targeting ERBB3 in Patients With Advanced Solid Tumors (NCT03552406) | ISU Abxis Co., Ltd. | 2018-04-27 |
| A Study to Investigate the Interaction Between Givosiran and a 5-probe Drug Cocktail in Patients With Acute Intermittent Porphyria (AIP) (NCT03505853) | Alnylam Pharmaceuticals | 2018-04-26 |
| Study of Loteprednol Etabonate in Adults Undergoing Bilateral Cataract Surgery (NCT03531697) | Sandoz | 2018-04-26 |
| Study of Proton Radiation to the Brain and Spinal Cord for Patients With Leptomeningeal Metastases (NCT03520504) | Memorial Sloan Kettering Cancer Center | 2018-04-26 |
| Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of JY09 (NCT04354090) | Beijing Dongfang Biotech Co., Ltd. | 2018-04-26 |
| A Study of CS1002 in Subjects with Advanced Solid Tumors (NCT03523819) | CStone Pharmaceuticals | 2018-04-26 |
| Study of PAN-90806 Eye Drops, Suspension for Neovascular AMD (NCT03479372) | PanOptica, Inc. | 2018-04-26 |
| Safety and Feasibility of Irradiation and Nivolumab in Esophageal Cancer (INEC) (NCT03544736) | Oslo University Hospital | 2018-04-26 |
| Atezolizumab and Stereotactic Body Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer (NCT02599454) | Megan Daly, MD | 2018-04-26 |
| Safety of Prasaprohyai 95%Ethanolic Extract Capsules in Healthy Volunteer (NCT03077282) | Thammasat University | 2018-04-26 |
| The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects (NCT03502902) | Sunshine Lake Pharma Co., Ltd. | 2018-04-26 |
| Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules (NCT03509883) | Bristol-Myers Squibb | 2018-04-26 |
| Randomized, Double-Blind, Placebo-Controlled, MAD Study to Assess the Safety, Tolerability, and Pharmacokinetics of SXC 2023 (NCT03542435) | Promentis Pharmaceuticals, Inc. | 2018-04-26 |
| EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations (NCT03516214) | University of Cologne | 2018-04-25 |
| Safety, Pharmacokinetics and Efficacy Study of Bisthianostat in Refractory or Recurrent Multiple Myeloma Patients (NCT03618602) | Shanghai Theorion Pharmaceutical Co Ltd. | 2018-04-25 |
| Evaluation of ETC-1907206 With Dasatinib in Advanced Haematologic Malignancies (NCT03414450) | EDDC (Experimental Drug Development Centre), A*STAR Research Entities | 2018-04-25 |
| A Phase 1b Study of the Selective HDAC Inhibitor Mocetinostat in Combination With Ipilimumab and Nivolumab in Patients With Unresectable Stage III or Stage IV Melanoma (NCT03565406) | NYU Langone Health | 2018-04-25 |
| CLN-0045: Safety, and Efficacy of OTX-TIC in Participants With Open Angle Glaucoma or Ocular Hypertension (NCT04360174) | Ocular Therapeutix, Inc. | 2018-04-25 |
| CPI-006 Alone and in Combination With Ciforadenant and With Pembrolizumab for Patients With Advanced Cancers (NCT03454451) | Corvus Pharmaceuticals, Inc. | 2018-04-25 |
| Safety, Tolerability and Pharmacokinetics of SH-1028 in Patients With Advanced NSCLC (NCT03603262) | Nanjing Sanhome Pharmaceutical, Co., Ltd. | 2018-04-25 |
| A Trial to Investigate Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BioChaperone® Pramlintide Insulin in Patients With Type 1 Diabetes Mellitus (NCT03512236) | Adocia | 2018-04-25 |
| Encorafenib + Binimetinib + Pembrolizumab in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma (NCT02902042) | Prof. Dr. med. Dirk Schadendorf | 2018-04-24 |
| Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513 (NCT03507569) | Hoffmann-La Roche | 2018-04-24 |
| Safety, Tolerability And Efficacy Study Of Topical PF-06763809 In Subjects With Mild To Moderate Chronic Plaque Psoriasis (NCT03469336) | Pfizer | 2018-04-24 |
| A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors (NCT03530397) | MedImmune LLC | 2018-04-24 |
| Phase I/Ib Multiple Ascending Dose Study in China (NCT03523390) | Merck KGaA, Darmstadt, Germany | 2018-04-24 |
| Calcium Electroporation for the Treatment of Colorectal Cancer (NCT03542214) | Zealand University Hospital | 2018-04-24 |
| CD19-targeting CAR T Cells in Relapsed or Refractory CD19 Positive B-cell Malignancies (NCT03559439) | Shanghai Tong Ren Hospital | 2018-04-24 |
| A Phase 1b Study of Sevacizumab in Combination With Chemotherapy in Chinese Patients With Platinum-Resistant Recurrent Ovarian Cancer. (NCT03763123) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2018-04-24 |
| A Study to Examine the Safety, Tolerability and Biological Effects of REGN4461 in Healthy Volunteers (NCT03530514) | Regeneron Pharmaceuticals | 2018-04-24 |
| Trial of AB-110 in Adults With Hematologic Malignancies Undergoing Cord Blood Transplantation (NCT03483324) | Angiocrine Bioscience | 2018-04-24 |
| Daprodustat Bioequivalence and Food Effect Study (NCT03493386) | GlaxoSmithKline | 2018-04-24 |
| A Dose Escalation and Confirmation Study of PT-112 in Advanced Solid Tumors in Combination With Avelumab (NCT03409458) | Promontory Therapeutics Inc. | 2018-04-24 |
| A Manufacturing Transfer Study Comparing the Bioequivalence of a Single Oral Dose of Claritin-D 12-Hour Extended Release Tablet From 2 Different Manufactuers Under Fed Conditions in Healthy Adult Subjects (NCT03517943) | Bayer | 2018-04-24 |
| Gene Therapy Study in Severe Hemophilia A Patients With Antibodies Against AAV5 (NCT03520712) | BioMarin Pharmaceutical | 2018-04-24 |
| Safety, Tolerability and Antimalarial Activity of Single Doses of OZ439 and PQP (NCT03542149) | Medicines for Malaria Venture | 2018-04-23 |
| Definitive QT Study With MT-8554 (NCT03471130) | Tanabe Pharma America, Inc. | 2018-04-23 |
| A Study of 18F-AlF-NOTA-Neurotensin PET/CT for Imaging Prostate Cancer (NCT03516045) | Xiangya Hospital of Central South University | 2018-04-23 |
| [18F]DASA-23 and PET Scan in Evaluating Pyruvate Kinase M2 Expression in Patients With Intracranial Tumors or Recurrent Glioblastoma and Healthy Volunteers (NCT03539731) | Guido A. Davidzon, MD, SM | 2018-04-23 |
| Micronutrients for Attention-Deficit Hyperactivity Disorder in Youth (MADDY) Study (NCT03252522) | Oregon Health and Science University | 2018-04-23 |
| A First in Human, Dose Escalation Study of JAB-3068 （SHP2 Inhibitor） in Adult Patients With Advanced Solid Tumors (NCT03518554) | Jacobio Pharmaceuticals Co., Ltd. | 2018-04-23 |
| A Study of TAK-164 in Participants With Advanced Gastrointestinal (GI) Cancer Expressing Guanylyl Cyclase C (GCC) (NCT03449030) | Millennium Pharmaceuticals, Inc. | 2018-04-23 |
| Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese Volunteer (NCT03488173) | First Affiliated Hospital of Zhejiang University | 2018-04-23 |
| A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers (NCT03827642) | INSYS Therapeutics Inc | 2018-04-23 |
| Pevonedistat in Combination With Ruxolitinib for Treatment of Patients With Myelofibrosis (NCT03386214) | Washington University School of Medicine | 2018-04-23 |
| Efficacy Study of Yi-Zhi-An-Shen Granules For Older Adults With Amnestic Mild Cognitive Impairment (NCT03601000) | Chengdu University of Traditional Chinese Medicine | 2018-04-21 |
| Glembatumumab Vedotin, Nivolumab, and Ipilimumab in Treating Patients With Advanced Metastatic Solid Tumors That Cannot Be Removed by Surgery (NCT03326258) | National Cancer Institute (NCI) | 2018-04-20 |
| Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT03515200) | St. Jude Children's Research Hospital | 2018-04-20 |
| Radio-Immuno-Modulation in Lung Cancer (NCT02579005) | Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | 2018-04-20 |
| A Study of ZN-e4 in Subjects With Epidermal Growth Factor Receptor Mutated Non-Small Cell Lung Cancer (NCT03446417) | Zeno Pharmaceuticals, Inc. | 2018-04-20 |
| A Study to Investigate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of TAK-079 Administered Subcutaneously as a Single Agent in Participants With Relapsed/Refractory (r/r) Multiple Myeloma (MM) (NCT03439280) | Millennium Pharmaceuticals, Inc. | 2018-04-20 |
| Addition of Azithromycin to Cefazolin Will Reduce Post CS Infections More Than Cefazolin Only. (NCT03502356) | Ain Shams University | 2018-04-20 |
| Evaluation of Pharmacokinetic Drug Drug Interaction Between PF-05221304 And PF-06865571 In Healthy Adult Subjects (NCT03534648) | Pfizer | 2018-04-19 |
| T-VEC in Non-melanoma Skin Cancer (NCT03458117) | University of Zurich | 2018-04-19 |
| Safety, Tolerability and PK of SHR1314 in axSpA (NCT03704428) | Jiangsu HengRui Medicine Co., Ltd. | 2018-04-19 |
| Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure (NCT03500731) | Paul Szabolcs | 2018-04-19 |
| A Phase I Clinical Study for Evaluating the Safety of MASCT-I in Advanced Soild Tumor (NCT03393416) | HRYZ Biotech Co. | 2018-04-19 |
| 177Lu-J591 and 177Lu-PSMA-617 Combination for mCRPC (NCT03545165) | Weill Medical College of Cornell University | 2018-04-18 |
| Study of AMG 596 in Patients With EGFRvIII Positive Glioblastoma (NCT03296696) | Amgen | 2018-04-18 |
| A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE) (NCT03556007) | Nektar Therapeutics | 2018-04-18 |
| Pevonedistat, Cytarabine, and Idarubicin in Treating Patients With Acute Myeloid Leukemia (NCT03330821) | University of Southern California | 2018-04-18 |
| A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment (NCT03374917) | AbbVie | 2018-04-18 |
| Single-dose Study of [14C]PF-05221304 Metabolism and Excretion in Healthy Adult Male Subjects (NCT03448172) | Pfizer | 2018-04-18 |
| A First-In-Human Study to Evaluate Safety, Tolerability, Reactogenicity, and Immunogenicity of JNJ-64300535, a DNA Vaccine, Administered by Electroporation-Mediated Intramuscular Injection, in Participants With Chronic Hepatitis B Who Are on Stable Nucleos(t)Ide Therapy and Virologically Suppressed (NCT03463369) | Janssen Sciences Ireland UC | 2018-04-18 |
| Bristol Imperial MDMA in Alcoholism Study (NCT04158778) | Imperial College London | 2018-04-18 |
| LRAs United as a Novel Anti-HIV Strategy. (NCT03525730) | Erasmus Medical Center | 2018-04-18 |
| Use of Allogenic Platelet Lysate in Peripheral Arterial Disease (PAD) (NCT03297814) | Sophia Al-Adwan | 2018-04-18 |
| A Clinical Study to Investigate the Effect of SAR425899 on Energy Expenditure in Obese Subjects (NCT03376802) | Sanofi | 2018-04-18 |
| Pilot Study of 18F-FMISO PET/CT and MRI Imaging to Explore Tissue Hypoxia and Arteriovenous Shunting in Subjects With Recurrent Glioblastoma Before and After Bevacizumab Treatment (NCT03573986) | Abramson Cancer Center at Penn Medicine | 2018-04-18 |